Summary
The Asian American population is characterized by remarkable diversity. Studying
Asians as an aggregate group may obscure clinically meaningful heterogeneity. We performed a population-based study using data from the US National Vital Statistics System. We determined the trends in age-standardized mortality rates for chronic liver disease stratified by aetiology among the most populous US-based Asian subgroups (Asian Indians, Chinese, Filipino, Japanese, Korean and Vietnamese) and compared it to non-Hispanic whites. Annual percentage change was calculated to determine temporal mortality patterns using joinpoint analysis. Hepatitis C virus-related mortality rates were higher in non-Hispanic whites compared to individual Asian subgroups, but a sharp decline in mortality rates was noted in 2014 among non-Hispanic whites and all Asian subgroups. Age-standardized hepatitis B virus-related mortality rates were higher in all Asian subgroups as compared to non-Hispanic whites in 2016, with the highest mortality among Vietnamese followed by Chinese. Mortality rates for alcoholic liver disease have been steadily trending upwards in all Asian subgroups, with the highest mortality in Japanese. Overall, age-standardized cirrhosis-related mortality rates were highest in non-Hispanic whites, followed by Japanese, and more distantly by Vietnamese and other subgroups. However, hepatocellular carcinoma-related mortality rates were higher in most Asian subgroups led by Vietnamese, Japanese and Koreans compared to non-Hispanic whites. In this population-based study utilizing a nationally representative database, we demonstrated a marked heterogeneity in the mortality rates of aetiologyspecific chronic liver disease among Asian subgroups in the United States.
K E Y W O R D S
Asian, end-stage liver disease, National Vital Statistic System United States based on the 2016 American Community Survey. 3 As a single group, Asian Americans showed remarkable heterogeneity, reflective of different countries of origin, cultural diversity, educational attainment, socio-economic status, immigration status, lifestyle patterns, insurance coverage, and accessibility of health services. 4, 5 Therefore, aggregating Asian Americans into a single group can mask important differences in disease burden and mortality rates. A few studies have described national trends in the health and mortality rates of Asians, [6] [7] [8] but overall mortality is lower in Asian Americans compared to non-Hispanic whites. 6 While these data are scant, a small number of studies have examined the trends in the mortality rates among Asian subgroups with results demonstrating a remarkable heterogeneity in the leading causes of death (e.g., cancer, cardiovascular disease, and stroke) between Asian American subgroups. 5, 6 However, aetiology-specific mortality rates in the setting of chronic liver disease among Asian subgroups in the United States on a national level have not been established and have been a limiting factor in improving access to care and addressing health disparities.
Several regional studies on state and city levels have attempted to describe the prevalence and patterns of aetiology-based chronic liver disease in Asian subgroups in the United States. These data showed marked differences in the prevalence of chronic liver diseases among Asian subgroups. In terms of chronic hepatitis B virus (HBV) infection, contrary to a lower prevalence rate of 0.5% in the general US population, the prevalence among Asian subgroups and communities ranges widely from 9% to 25%. [9] [10] [11] [12] Regarding chronic hepatitis C virus (HCV) infection, estimates of national prevalence range from 1.6% to 2%, 13 but the prevalence of HCV in Asian subgroups ranges from 2.9% to 5.2% in local community-based screening studies. [14] [15] [16] These data emphasize the importance of improving the understanding of aetiology-based prevalence, trends, and outcomes of cirrhosis, hepatocellular carcinoma (HCC) and chronic liver disease among Asian subgroups. We hypothesized that there are disproportionate differences in chronic liver disease-related mortality across Asian subgroups in the United States, which potentially resulted in obscure heterogeneity that is not characterized and masked by aggregating Asians into a single group. We examined temporal trends in aetiology-based chronic liver disease-related mortality rates utilizing the US National Vital Statistics System (NVSS) database. We focused on HCV, alcoholic liver disease (ALD), HBV, cirrhosis, and HCC among the six largest Asian subgroups (Asian Indians, Chinese, Filipinos, Japanese, Koreans and Vietnamese) from 2007 to 2016.
| MATERIAL S AND ME THODS

| Study data
We utilized deidentified US national mortality data from the NVSS and analysed it to determine trends in chronic liver disease-related mortality rates. The NVSS database stores death certificate records of >99% of deaths in the 50 states and the District of Columbia.
Data for the population under 20 years of age were excluded as they were unreliable due to a small number of events. Cause of death was coded using the International Classification of Diseases, Tenth
Revision (ICD-10), with each observation corresponding to one death and the demographics associated with that person. Cause of death was incorporated into three fields: underlying cause of death, the entity axis and the record axis. 17 The underlying cause of death field lists the one condition which leads to death; the entity axis includes all causes of death on the death certificate; and the record axis provides a modified version of the entity axis in which related conditions are combined, and overlapping conditions are eliminated. 17 Additionally, within the record axis, causes violating logical checks are deleted in an effort to promote specificity and resolve contradictions. 17 As the record axis provides the higher specificity, this was utilized for determining the contributing cause of death. 
| Statistical analysis
Age-standardized mortality rates were determined by dividing the number of deaths from a given chronic liver disease by the total US census population among Asian subgroups and non-Hispanic whites for each year. Age-standardized mortality rates per 100 000
persons by race/ethnicity and by age groups ( 731 (1) 1985 ( 50-59, 60-69, 70-79, and ≥80 years) were calculated. The population for each Asian subgroup was calculated using previously described Table S1 . Most
| RE SULTS
Asian subgroups are largely composed of new immigrants with exception to Japanese.
| Age-standardized mortality for chronic liver disease among Asian subgroups
Trends in age-standardized HCV-related mortality rates are shown in Figure 1A and Table 2 . There was a steady increase in age- When we analysed our data using the underlying cause of death for sensitivity analysis (Table S2 and Figure S1 ), age-standardized viral hepatitis-related mortality rates in Asians declined more markedly ALD had a substantially higher mortality in non-Hispanic whites as compared to all Asians over the study period ( Figure 1C , Table 2 ). 
Mortality in non-
| Age-standardized mortality for cirrhosis and HCC among Asian subgroups
Mortality related to cirrhosis was almost approximately threefold higher among non-Hispanic whites than all Asians through the study period ( Figure S2A , Table 3 ). We observed a statistically significant average APC increase of 3.0% (95% CI 2.6 to 3.4) in non-Hispanic whites, while all Asians remained stable during study periods. Non- As shown in Figure S2B , all Asians had a higher age-standardized mortality rate than non-Hispanic whites for HCC-related mortality.
There was a statistically significant trend segment decrease in HCCrelated mortality among all Asians overall (APC −2.0%, 95% CI −3.6 to −0.5) with a more abrupt decline of −3.5% (95% CI −4.6 to −2.4) from 2009 to 2016. The highest rates of HCC-related mortality were seen in Vietnamese, trailed by Japanese, and Koreans as compared to non-Hispanic whites. In particular, a statistically significant annual increase of 1.8% (95% CI 0.4 to 3.2) was observed in Vietnamese.
However, a steady linear decrease in HCC-related mortality was observed in the Chinese subgroup over the 10-year period (APC −2.5%, 95% CI −4.7 to −0.3). In the sensitivity analysis using underlying cause of death (Table S2 and Figure S1 ), age-standardized chronic liver disease and cirrhosis-related mortality rates in Asians 
| D ISCUSS I ON
This population-based study of nationally representative mortality data revealed remarkable heterogeneity across Asian American subgroups in trends of mortality from chronic liver disease in the United
States. Previously, population-based studies aggregated Asians as a single ethnicity/race which may obfuscate some meaningful differences between Asian subgroups. By examining disaggregated
Asian subgroups, we found that the highest rates of cirrhosis-related mortality were observed in Japanese and Vietnamese. Consistent with a prior study, 6 HCC-related mortality was higher in most Asian subgroups than in non-Hispanic whites with highest mortality rates observed in the Vietnamese and Japanese. Interestingly, while observed mortality rates are different between non-Hispanic whites and all Asians, the overall trends over time are consistent with a decline in HBV and HCV-related mortality accompanied by an increase in ALD-related mortality with wide variation among different Asian subgroups. These differences highlight area of possible future investigation in ethnicity/race-based epidemiological studies and more importantly can help to guide efforts to reach disproportionately affected Asian subgroups-targeted linkage to care, prompt diagnosis and access to treatment.
In terms of aetiologies of chronic liver disease, HBV-related mortality rates in Asians were markedly higher than in non-Hispanic whites, consistent with the higher prevalence of chronic HBV in Asians. [9] [10] [11] 15 Likewise, trends in mortality rates also reflected the higher prevalence noted in Vietnamese and Chinese amongst the Asian subgroups. 14, 15 These data, as well as experience from prior and existing programs, clearly support the targeted interventions in Asian subgroups. 19, 20 The ALD-related mortality rates in Asian
Americans were markedly lower than in non-Hispanic whites but did increase over the study period with an annual 2.2% increase (CI 0.5 to 4.0). The highest rates of ALD-related mortality were noted The highest age-adjusted HCC incidence rates (>20/100 000) are found in Eastern Asia (China, Korea and Vietnam) and sub-Saharan Africa. 22 In 2012, Eastern Asia was noted to have the highest HCCrelated incidence and mortality in both genders in the World. 23 According to Asian-Pacific clinical practice guideline, there was a clear difference of incidence and mortality in this region. 22 For example, the cause of HCC in Japan (mainly HCV) differs greatly from other countries (mainly HBC) in the region. Nationwide programs for HCC surveillance or HBV vaccination were introduced variably in each country. 22 With exception of Japanese, all other Asian Americans were 70% foreign-born immigrants. Therefore, advanced liver disease such as cirrhosis and HCC among Asian
Americans indicate that the liver disease was acquired most likely in the country of origin.
The strength of this study includes the capture of national trends in chronic liver disease mortality, allowing for insight into disparities among Asian subgroups. Additionally, portal hypertension-related complications, such as spontaneous bacterial peritonitis or variceal bleeding, which are the most likely cause of mortality, were captured in the cirrhosis category. These are likely more reliable estimates than those provided in the National Vital Statistics Report which is based on diagnosis codes of "chronic liver disease and cirrhosis," which may fail to capture mortality attributed to complications of portal hypertension and HCC. 24 This study has several limitations in its design and analysis of mortality data. As it relies on the cause of death based on death certificates, it can be affected by underestimation and misclassification. However, the coding methodology has been constant over the study period and thus the trends described above 
